🎯

HYPO-RT-PC

SBRT

Definitive - HYPO-RT-PC Trial - 42.7 Gy/7 fx

Dose Oracle
PREFERRED42.7 Gy / 7 fx(6.1 Gy/fx)BED₁₀ = 68.7 Gy• HYPO-RT-PC ultra-hypofractionation

Indication

Intermediate-risk prostate cancer, 7-fraction ultra-hypofractionation

Eligibility Criteria

  • Intermediate-risk prostate cancer
  • T1b-T3a N0 M0
  • PSA <20 ng/mL
  • No prior RT to pelvis
  • IPSS score <20

Staging

T1b-T3a N0 M0

Tags

SBRTProstate7 fractionDefinitiveIntermediate-riskSwedish